Development of pyrrolopyrimidine-based ACK1 inhibitors for cancer therapeutics

被引：0
|
作者：
Matar, Angelie
Marusyk, Yuliya
Ranatunga, Sujeewa
Rowsell, Tegan
Amin, Narmin
Walker, Hannah
Tran, Timothy
Yang, Kathy
Duckett, Derek
Reuther, Gary
Lawrence, Harshani
Lawrence, Nicholas
机构：
来源：
CANCER RESEARCH | 2023年 / 83卷 / 07期
关键词：
D O I：
10.1158/1538-7445.AM2023-3096
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
3096
引用
收藏
页数：2
相关论文
共 50 条
  • [21] Identification of an ACK1/TNK2-based prognostic signature for colon cancer to predict survival and inflammatory landscapes
    Defeng Kong
    Guoliang Li
    Zhenrong Yang
    Shujun Cheng
    Wen Zhang
    Lin Feng
    Kaitai Zhang
    BMC Cancer, 22
  • [22] Identification of an ACK1/TNK2-based prognostic signature for colon cancer to predict survival and inflammatory landscapes
    Kong, Defeng
    Li, Guoliang
    Yang, Zhenrong
    Cheng, Shujun
    Zhang, Wen
    Feng, Lin
    Zhang, Kaitai
    BMC CANCER, 2022, 22 (01)
  • [23] Integrating Clinical Cancer and PTM Proteomics Data Identifies a Mechanism of ACK1 Kinase Activation
    Balasooriya, Eranga R.
    Madhusanka, Deshan
    Lopez-Palacios, Tania P.
    Eastmond, Riley J.
    Jayatunge, Dasun
    Owen, Jake J.
    Gashler, Jack S.
    Egbert, Christina M.
    Bulathsinghalage, Chanaka
    Liu, Lu
    Piccolo, Stephen R.
    Andersen, Joshua L.
    MOLECULAR CANCER RESEARCH, 2024, 22 (02) : 137 - 151
  • [24] Effect of set up protocols on the accuracy of alchemical free energy calculation over a set of ACK1 inhibitors
    Granadino-Roldan, Jose M.
    Mey, Antonia S. J. S.
    Perez Gonzalez, Juan J.
    Bosisio, Stefano
    Rubio-Martinez, Jaime
    Michel, Julien
    PLOS ONE, 2019, 14 (03):
  • [25] Development of CDK inhibitors as cancer therapeutics
    D Lane
    Breast Cancer Research, 7
  • [26] Development of CDK inhibitors as cancer therapeutics
    Lane, D
    BREAST CANCER RESEARCH, 2005, 7 (Suppl 2) : S14 - S14
  • [27] KDM3A tyrosine phosphorylation by Ack1 promotes tamoxifen-resistance in breast cancer
    Mahajan, Kiran
    Bandyopadhyay, Sayantani
    Mahajan, Nupam
    CANCER RESEARCH, 2014, 74 (19)
  • [28] Development of glutaminase inhibitors for cancer therapeutics
    Zimmermann, Sarah
    Wolf, Emily
    Luu, Andrew
    Thomas, Ajit
    Alt, Jesse
    Poore, Brad
    Le, Anne
    Rais, Rana
    Slusher, Barbara
    Tsukamoto, Takashi
    ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 2016, 251
  • [29] QSAR study of ACK1 inhibitors by genetic algorithm-multiple linear regression (GA-MLR)
    Pourbasheer, Eslam
    Aalizadeh, Reza
    Ganjali, Mohammad Reza
    Norouzi, Parviz
    Shadmanesh, Javad
    JOURNAL OF SAUDI CHEMICAL SOCIETY, 2014, 18 (05) : 681 - 688
  • [30] Comprehensive Analysis of the Immune Implication of ACK1 Gene in Non-small Cell Lung Cancer
    Zhu, Jinhong
    Liu, Yang
    Ao, Haijiao
    Liu, Mingdong
    Zhao, Meng
    Ma, Jianqun
    FRONTIERS IN ONCOLOGY, 2020, 10
12345